Diclofenac sodium
Olfen 100 SR and Diclofenac-ratiopharm 100 mg Retard capsules are different trade names for the same medicine.
Olfen 100 SR belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs), which are used to treat pain and inflammation.
Olfen 100 SR relieves the symptoms of inflammatory conditions, such as swelling and pain. It does not affect the causes of inflammation and fever.
Olfen 100 SR can be used to treat pain and inflammation in cases of:
In case of doubts about the action or reasons for prescribing Olfen 100 SR, you should consult a doctor.
You should follow all the instructions given by your doctor or pharmacist carefully, even if they differ from the general information contained in this leaflet.
If any of the above symptoms occur in the patient, they should inform their doctor and not take Olfen 100 SR until the doctor determines that the medicine is suitable for the patient.
Olfen 100 SR should not be taken by children and adolescents.
Before starting treatment with Olfen 100 SR, the patient should discuss it with their doctor, pharmacist, or nurse.
The patient should inform their doctor if:
Before taking diclofenac, the patient should inform their doctor
Before taking Olfen 100 SR, the patient should tell their doctor if they have recently undergone or are scheduled to undergo stomach or gastrointestinal surgery, as Olfen 100 SR may sometimes cause weakening of the healing process of gut wounds after surgery.
The occurrence of side effects can be reduced by taking the medicine in the smallest effective dose and for no longer than necessary.
If any of the above warnings apply to the patient, they should inform their doctor before taking Olfen 100 SR.
Other special warnings
Olfen 100 SR should not be taken at the same time as other systemically acting NSAIDs, including selective cyclooxygenase-2 inhibitors.
Taking medicines like Olfen 100 SR may be associated with a small increased risk of heart attack ("myocardial infarction") or stroke. Any risk is more likely with higher doses and longer treatment. The recommended dose or duration of treatment should not be exceeded.
In case of heart problems, a history of stroke, or suspected risk of these disorders (e.g., high blood pressure, diabetes, high cholesterol, or smoking), the patient should discuss their treatment with their doctor or pharmacist.
Olfen 100 SR may reduce the symptoms of infection (e.g., headache, high temperature), making it more difficult to diagnose and treat the infection effectively. If the patient feels unwell and needs to see a doctor, they should inform them that they are taking Olfen 100 SR.
In very rare cases, Olfen 100 SR, like other anti-inflammatory medicines, may cause severe skin allergic reactions (e.g., exfoliative dermatitis, Stevens-Johnson syndrome with widespread rash, high fever, and joint pain, and toxic epidermal necrolysis with skin and mucous membrane lesions, high fever, and severe general condition). Therefore, the patient should inform their doctor if such reactions occur. In rare cases, Olfen 100 SR, like other anti-inflammatory medicines, may cause allergic reactions, including severe allergic reactions, even if the medicine has not been taken before.
Elderly patients
Elderly patients may be more sensitive to the effects of Olfen 100 SR.
Therefore, they should follow their doctor's instructions carefully and take the minimum effective dose that provides relief from symptoms. It is especially important for patients to report any side effects to their doctor immediately.
The patient should tell their doctor or pharmacist about all the medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
It is especially important to inform the doctor about taking any of the following medicines:
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
Pregnancy
Olfen 100 SR should not be taken if the patient is in the last three months of pregnancy, as it may harm the unborn baby or cause complications during delivery. Olfen 100 SR may cause kidney and heart problems in the unborn baby. It may also increase the risk of bleeding in the mother and baby and prolong labor. During the first six months of pregnancy, Olfen 100 SR should not be taken unless the doctor considers it absolutely necessary. If treatment is necessary during this period or when trying to conceive, the smallest effective dose should be used for the shortest possible time. From the 20th week of pregnancy, Olfen 100 SR may cause kidney problems in the unborn baby if taken for more than a few days - this may lead to low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of the arterial duct (ductal constriction) in the baby's heart. If treatment is required for a longer period, the doctor may recommend additional monitoring.
Breastfeeding
Olfen 100 SR should not be taken while breastfeeding, as it may harm the baby.
Fertility
Diclofenac may make it more difficult to become pregnant. The patient should inform their doctor if they plan to become pregnant or are having trouble becoming pregnant.
The patient should not drive or operate any machinery if they experience side effects while taking Olfen 100 SR, such as vision disturbances, dizziness, drowsiness, or other central nervous system disorders.
If the patient has been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per prolonged-release hard capsule, which means the medicine is considered "sodium-free".
This medicine should always be taken as directed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist.
The doctor will tell the patient exactly how to take Olfen 100 SR. Depending on the patient's individual response to treatment, the doctor may recommend a higher or lower dose of the medicine.
The patient should not exceed the recommended dose. It is important to take the smallest effective dose for the shortest period necessary to control the symptoms and not to take Olfen 100 SR for longer than necessary.
The doctor will tell the patient exactly how to take Olfen 100 SR. Depending on the patient's individual response to treatment, the doctor may recommend a higher or lower dose of the medicine.
Adults
The recommended initial daily dose is 100 mg to 150 mg.
The recommended dose for adults is 1 capsule per day (100 mg of diclofenac sodium), unless the doctor recommends otherwise.
If necessary, therapy may be combined with a dose of 25 mg or 50 mg in the form of tablets or suppositories to a maximum dose of 150 mg of diclofenac sodium per day.
Patients with kidney and liver disorders
In patients with mild and moderate kidney or liver disorders, there is no need to adjust the dose.
Elderly patients
When taking Olfen 100 SR in elderly patients, special caution should be exercised, and the smallest effective dose should be used for the shortest period necessary to relieve symptoms. The patient should be regularly monitored for the possibility of gastrointestinal bleeding.
Children and adolescents
Olfen 100 SR should not be taken by children and adolescents.
The capsules should be swallowed whole before meals, without chewing, and washed down with a glass of water.
The patient should not exceed the recommended dose.
The patient should strictly follow their doctor's instructions.
If the patient accidentally takes a higher dose of Olfen 100 SR than recommended, they should inform their doctor or pharmacist or go to the hospital emergency department immediately. Medical attention may be necessary.
If the patient misses a dose, they should take it as soon as they remember. If it is almost time for the next dose, they should take the next dose at the usual time. The patient should not take a double dose to make up for the missed dose.
If the patient has any further doubts about taking this medicine, they should consult their doctor or pharmacist.
Like all medicines, Olfen 100 SR can cause side effects, although not everybody gets them.
Some side effects can be serious.
During treatment with Olfen 100 SR, the following side effects have occurred with the following frequencies: very common: more than 1 in 10 patients; common: 1 in 10 to 1 in 100 patients; uncommon: 1 in 100 to 1 in 1,000 patients; rare: 1 in 1,000 to 1 in 10,000 patients; very rare: less than 1 in 10,000 patients; frequency not known (frequency cannot be estimated from available data).
If the patient experiences any of the above symptoms, they should inform their doctor immediately.
Common:occurs in 1 to 10 in 100 patients
Rare:occurs in 1 to 10 in 10,000 patients
Very rare:occurs in less than 1 in 10,000 patients
Medicines like diclofenac may slightly increase the risk of heart attack or stroke. The risk of this is more likely with higher doses and longer treatment. The patient should not exceed the recommended dose or duration of treatment.
The patient should inform their doctor if they experience any of the above side effects.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should consult their doctor, pharmacist, or nurse.
If Olfen 100 SR is taken for more than a few weeks, the patient should have regular check-ups with their doctor to ensure that no unnoticed side effects have occurred.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
The patient should not take this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
The medicine should not be stored above 25°C.
Translation of some information on the immediate packaging:
Ch.-B. und verwendbar bis: siehe Prägung -Batch number and expiry date: see imprint
The patient should not throw away medicines via wastewater or household waste. They should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Hard gelatin capsule with a pink cap and a white, opaque body with the imprint "100". The capsule contains white to pale yellow pellets.
PVC-Aluminum blisters in a cardboard box.
The pack contains 10 or 20 prolonged-release hard capsules.
For more detailed information, the patient should contact the marketing authorization holder or parallel importer.
ratiopharm GmbH
Graf-Arco-Str. 3
89079 Ulm
Germany
Merckle GmbH, Ludwig-Merckle-Str. 3, 89143 Blaubeuren, Germany
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in Germany, the country of export:4369.00.03
Parallel import authorization number:373/21
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.